January 23, 1998 |
A quarter of men have high levels of a growth protein linked to a greater likelihood of prostate cancer, says a new study that may point scientists toward ways to reduce the incidence of the cancer. Dr. Michael Pollak of McGill University, who coauthored the study with Harvard University scientists, said if the new research is confirmed, doctors may one day use the protein to better predict which men will one day get cancer.
CALIFORNIA | LOCAL
June 8, 2000 |
Los Angeles County public health officials announced Wednesday that an outbreak of syphilis primarily among gay men appears to be subsiding. Dr. James Haughton, medical director of public health for Los Angeles County, said that despite increased surveillance and testing, just one new case of syphilis has been reported in the last six weeks. "We are hoping the outbreak has peaked and is waning now," he said.
September 16, 1998 |
A study raised questions about a widely used prostate cancer radiation therapy in cases where there is a high risk the disease will spread. Researchers at Harvard Medical School said a nearly four-year study involving 1,872 men found poorer outcomes for high-risk patients treated by implanting radioactive "seeds" in the gland, compared with those treated more aggressively. The study, published in Chicago in the Journal of the American Medical Assn.
March 7, 1997
"It's one of the worst cancers to die of. It's characterized by widespread bone pain, which is almost an intractable pain for us to deal with, and the terminal phases last a year or two or even longer." --Thomas E. Ahlering MD, chief of urology, UC Irvine College of Medicine "Search for the first time the word 'prostate' was mentioned in your newspaper. It was not before 1960 or '70, I'll tell you that, even though it was a major disease in this country. No one talked about this." --Donald F.
January 1, 1997 |
A new blood test holds promise of predicting possible cases of prostate cancer up to 10 years before the disease can be diagnosed, a six-year jump on current methods, scientists reported. The new test involves a different way of monitoring the enzyme PSA, or prostate specific antigen, in a man's blood, according to researchers at the National Institute on Aging and the Johns Hopkins University School of Medicine.
August 21, 1996 |
A little-known form of "bad" cholesterol that doctors cannot yet measure reliably may cause early heart disease just as often as its better-known cousins, a study suggests. The lesser-known culprit, called lipoprotein(a), may lurk in dangerously high levels in the blood of people whose other cholesterol levels appear normal on routine tests, researchers say.
March 16, 1996 |
New studies from Rhode Island and Germany found that shorter men face a greater risk of heart trouble and high blood pressure. The study of 6,589 Rhode Islanders looked at how other men compared with those who stood between 5 feet 7 inches and 5 feet 8 inches. Those under 5 feet 5 inches had a risk of heart disease that was double that of the moderate-size men, while men over 5 feet 10 inches had a risk that was 60% lower.
November 22, 1996 |
Defying what some believed to be insurmountable odds, researchers have narrowed the search for a prostate cancer gene to one small corner of the human genetic blueprint, a finding that promises improved diagnosis, new treatments and better survival rates for this most common of male cancers. An estimated 317,000 American men are diagnosed with prostate cancer each year and 40,000 die from it.
May 6, 1996 |
A pill that restores full function to impotent men is now in the final phases of clinical testing and could be offered for sale in the United States late next year, a British scientist says. The drug sildenfil blocks the action of an enzyme in the penis that tends to aggravate impotence, said Dr. Ian Osterloh, a researcher for Pfizer Inc. in Britain. "The pill is taken an hour or so before it is needed," said Osterloh. "It will do nothing, however, in the absence of sexual stimulation."